Holen Sie sich die Stockscreener-App
1.9253
2.59%
-0.0047
Schlusskurs vom Vortag:
$1.93
Offen:
$1.93
24-Stunden-Volumen:
12,522
Relative Volume:
0.11
Marktkapitalisierung:
$5.00M
Einnahmen:
$102.80K
Nettoeinkommen (Verlust:
$-5.32M
KGV:
-0.5067
EPS:
-3.8
Netto-Cashflow:
$-5.45M
1W Leistung:
-4.57%
1M Leistung:
-14.55%
6M Leistung:
-42.15%
1J Leistung:
-57.27%
1-Tages-Spanne:
$1.85
$1.9648
1-Wochen-Bereich:
$1.85
$2.10
52-Wochen-Spanne:
$1.69
$6.90
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Firmenname
Creative Medical Technology Holdings Inc
Sektor
Branche
Telefon
480-399-2822
Adresse
211 E. OSBORN RD., PHOENIX
Vergleichen Sie CELZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
1.9109 | 5.00M | 102.80K | -5.32M | -5.45M | -3.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.68 | 125.74B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
595.76 | 61.57B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
607.10 | 36.40B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.00 | 30.36B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
248.08 | 24.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Creative Medical Technology Holdings Inc Aktie (CELZ) Neueste Nachrichten
Creative Foam buys medical supplier AccuMed from Lear - Plastics News
Venus Shines Again, ENZ To Be Delisted, SLP, CERT On Watch - RTTNews
Head-To-Head Contrast: Atara Biotherapeutics (NASDAQ:ATRA) and Creative Medical Technology (NASDAQ:CELZ) - Defense World
Exosomes Drug Market Projected To Witness Substantial Growth, - openPR.com
Mergers & Acquisitions Tracker - Plastics News
Longevity Health to combine with 20/20 BioLabs in all-stock deal (XAGE:NASDAQ) - Seeking Alpha
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Exosomes Market Detailed In New Research Report 2025 | Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC - newstrail.com
CELZ stock touches 52-week low at $1.9 amid market challenges - Investing.com Canada
CELZ stock touches 52-week low at $1.9 amid market challenges By Investing.com - Investing.com South Africa
Creative Medical Technology files to sell 1.8M shares of common stock by selling shareholders - MSN
Pre-market Movers: ICCT, CTOR, PCVX, AIM... - RTTNews
Creative Medical Technology (NASDAQ:CELZ) versus Immunocore (NASDAQ:IMCR) Head to Head Comparison - Defense World
CELZ stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What is Roth Capital’s Forecast for CELZ FY2027 Earnings? - Defense World
Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World
Creative Medical Technology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
FDA approves expanded trial for back pain cell therapy By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings Secures FDA Clearance For Expanded Dosing In Back Pain Trial - Nasdaq
FDA approves expanded trial for back pain cell therapy - Investing.com India
Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial -March 20, 2025 at 08:27 am EDT - MarketScreener
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain - The Manila Times
FDA Green Light: Breakthrough Cell Therapy Shows Promise in Chronic Back Pain Treatment - Stock Titan
Nanoparticle Drug Delivery Market Growth, Generated - openPR.com
Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Game-Changing: Family-Owned Business Thrives for Over a Century - GeeksULTD
Just Revealed: Crescent Market Beaumont Family-Owned for 100+ Years - GeeksULTD
Apple Stock Forecast: Where Will It Be In 5 Years? - GeeksULTD
Revolutionary: Stem Cell Therapy Puts Creative Medical on Profit Track - GeeksULTD
Sexual Assault in South Sudan: Experts Stunned by Breakthrough Technology - GeeksULTD
Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit - Yahoo
When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Simply Wall St
Delaware Court Just Changed the Game for Big Business - GeeksULTD
Shocking: Trump Tariffs Spark Market Sell-Off - GeeksULTD
Trump Tariffs in Chaos: Markets React - GeeksULTD
Breaking: Trump Trade War Exposes Hidden Dangers - GeeksULTD
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC 10-K Report - TradingView
Hyde Park Capital Advises Infiniti Medical on its Sale to CIMA Animal Health, a Portfolio Company of Incline Equity Partners - The Malaysian Reserve
Exosomes Drug Market Detailed In New Research Report 2025 | Thermo Fisher Scientific, Inc., Bio-Techne - openPR
Exosomes Market Projected To Witness Substantial Growth, 2025-2032: Bio-Techne, QIAGEN, Lonza, Miltenyi - EIN News
Creative Medical Technology secures $3.7 million through warrants By Investing.com - Investing.com Australia
Where are the Opportunities in (CELZ) - Stock Traders Daily
Creative Medical Technology secures $3.7 million through warrants - Investing.com India
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross - EIN News
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds - The Manila Times
Heritage Distilling Co. Announces Recent Achievements and Key Milestones for Salute Series Line of Premium Whiskeys - The Manila Times
Creative Medical Technology Holdings Announces Agreements For Exercise Of Warrants For $3.7 Million Gross Proceeds - MENAFN.COM
Can This $3.7M Cash Injection Fuel Creative Medical's Next Growth Phase? - StockTitan
Finanzdaten der Creative Medical Technology Holdings Inc-Aktie (CELZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
Creative Medical Technology Holdings Inc-Aktie (CELZ) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Finger Michael H. | Director |
Feb 18 '25 |
Sale |
5.00 |
750 |
3,750 |
1,101 |
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):